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ABSTRACT
Objective: Adherence is increasingly recognized as an important determinant of successful HIV treatment (also called antiretroviral therapy [ART]). 
Poor adherence may cause ART failure and increase the risk of drug resistance. No prior studies have explained the reasons for poor adherence to ART 
among HIV-infected patients in Indonesia. This study aimed to investigate the determinants of adherence to ART among HIV-infected patients using 
precede–proceed model and path analysis.
Methods: This was an analytic observational study with a cross-sectional design. The study was carried out at Dr. Moewardi Hospital, Surakarta, 
Central Java, Indonesia, from January to March 2018. A total of 284 HIV-infected patients visiting Dr. Moewardi Hospital for ART was selected for 
this study by simple random sampling. The dependent variable was adherence to ART. The independent variables included adverse effect, patient 
knowledge, income, depression, trust in provider, ART supply by the government, family support, stigma, discrimination, distance, and travel 
expenditure. The data were collected by pre-tested questionnaire and analyzed by path analysis.
Results: Adherence to ART was directly and positively affected by government supply of ART (b=2.10; 95% confidence interval (CI)=0.85–3.36; 
p<0.001), patient knowledge (b=1.70; 95% CI= 0.43–2.95; p=0.008), and trust in provider (b=2.14; 95% CI=−0.58–4.87; p = 0.123). Adherence was 
directly but negatively affected by adverse effect (b=−4.17; 95% CI=−6.87–−1.47 ; p=0.879), depression (b=−2.38; 95% CI=−4.15–−0.62 ; p=0.002), 
stigma (b=−4.10; 95% CI=−6.49–−1.71; p=0.008), and travel expenditure (b=−1.52; 95% CI=−2.68 to −0.36; p<0.001).
Conclusion: Adherence is indirectly and positively affected by patient satisfaction, income, family support, but indirectly and negatively affected 
by discrimination and distance. This study concludes that government supply of ART, patient knowledge, and trust in provider, positively affect 
adherence to ART. Adverse effect, depression, stigma, and travel expenditure negatively affect adherence.
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INTRODUCTION
Adherence is increasingly recognized as an important determinant 
of successful antiretroviral therapy (ART) even if it is provided free 
of charge [1]. Adherence refers to sticking firmly to an HIV regimen 
everyday and exactly as prescribed. Treatment adherence includes 
initiating care with an HIV provider (linkage to care), regularly 
attending appointments (retention in care), and adherence to AR  [2-5]. 
HIV regimens can include numerous pills with frequent dosing and 
various, sometimes conflicting, food requirements [6].
Poor adherence can lead to ART failure. Poor adherence to an HIV 
regimen allows HIV to destroy the immune system and a damaged 
immune system makes it hard for the body to fight off infections and 
certain cancers. As studies have shown, poor CD4 gain in HIV-infected 
patient follows poor adherence [7].
Moreover, poor adherence increases the risk of drug resistance [8]. Drug 
resistance refers to the ability of disease-causing germs, such as bacteria 
and viruses, to continue multiplying despite the presence of drugs that 
usually kill them. Drug resistance can develop as HIV multiplies in the 
body. When HIV multiplies, the virus sometimes mutates (changes form) 
and makes genetic structural variations of itself. Failure to take the 
prescribed doses of antiretroviral drugs leads to ongoing viral replication 
in the presence of drug and the selection of drug-resistant HIV [9].
Taking HIV medicines everyday prevents HIV from multiplying, which 
reduces the risk that HIV will mutate and produce drug-resistant HIV. 
Otherwise, skipping HIV medicines allows HIV to multiply, which 
increases the risk of drug-resistant HIV developing. However, in a 
developed country such as the US with relatively better health-care 
system than most developing countries, after receiving an HIV diagnosis, 
only about 75% of individuals are linked to care within 30 days. Only 
57% of persons who receive an HIV diagnosis are retained in HIV care. 
Moreover, it is estimated that only approximately 55% of persons with 
diagnosed HIV are virally suppressed because of poor linkage to care 
and retention in care [10]. On top of that, as is the case in other serious 
illness, medication non-adherence places a significant cost burden on 
health-care systems [11].
Non-adherence, however, is a complicated phenomenon and decades 
of research have attempted to establish its clear connection with 
variables that can be altered and improved in the course of HIV/AIDS 
clinical care. A commonly cited cause of poor adherence to highly 
active antiretroviral therapy (HAART) is adverse drug reactions [5]. 
Adverse effects from some HIV medicines, such as nausea or diarrhea, 
can make it hard to follow an HIV regimen. Adverse events may lead 
to discontinuation of therapy, dose interruption, and significant 
reductions in quality of life [12].
The precede–proceed model is a comprehensive structure for assessing 
health needs for designing, implementing, and evaluating health 
promotion and other public health programs to meet those needs. This 
model was first developed and introduced in the 1970s by Lawrence et 
al. [13]. It is an ecological approach to health promotion, which embodies 
two key aspects of intervention: (a) planning (precede component) and 
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(b) evaluation (proceed component). The precede component includes 
an ecological assessment that analyzes the predisposing, reinforcing, and 
enabling factors that determine the behavior in question (i.e. adherence 
to HIV treatment in the current study) [14].
To the best of the authors knowledge, there were no prior studies that 
explained the reasons for poor adherence to HIV treatment among HIV-
infected patients in Indonesia using precede–proceed model as the 
conceptual framework and path analysis as the data analytic approach. 
Therefore, the current study aimed to investigate the determinants of 
adherence to HIV regimen among HIV-infected patients in Indonesia 
using the precede–proceed model and path analysis approach. 
Information from the current study can be used to develop a system of 
care and support that can improve adherence to antiretroviral therapy 
and the well-being of HIV-infected patients.
METHODS
Study design
This study was analytic-observational with a cross-sectional design. 
It was conducted at Dr. Moewardi Hospital, Surakarta, Central Java, 
Indonesia, from February to March 2018.
Population and sample
A total of 284 study subjects was selected for this study by exhaustive 
sampling from all HIV-infected patients who visited Dr. Moewardi 
hospital for ART from February to March 2018.
Study variables
The dependent variable was adherence to ART (coded 0 - poor; 
1 - good). The independent variables included the biological and 
psychosocial variables, which fell into three categories: predisposing, 
enabling, and reinforcing factors of the precede–proceed model.
The predisposing factors included adverse effect (coded 0 - absent; 1 
- present), patient’s knowledge (coded 0 - low; 1 - high), income (coded 
0≤ Rp 1,500,000; 1≥ Rp 1,500,000 per month), satisfaction (coded 0 
- low; 1 - high), depression (coded 0 - low; 1 - high), and trust in provider 
(coded 0 - low; 1 - high). The enabling factors included ART supply by 
the government (coded 0 - late; 1 - timely).
The reinforcing factors included family support (coded 0 - weak; 
1 - strong), stigma (coded 0 - weak; 1 - strong), discrimination (coded 
0 - non-existent; 1 - existent), distance to ART centers (coded 0≤20 km; 
1≥20 km), and travel expenditure (coded 0 - low; 1 - high).
Adherence to ART was defined as the patient’s behavior on the number 
of pills taken, timeliness of visit to the ART center, accuracy of dose, and 
percentage of the total amount of prescribed medication. This variable 
was measured by self-reported questionnaire coupled with data from 
the secondary record in the voluntary counseling and testing clinic at 
Dr. Moewardi Hospital.
Stigma was defined as a mark of disgrace that a society gave to HIV-
infected patients. Discrimination was defined as the unjust or prejudicial 
treatment of the patients, on the grounds of HIV infection status, which 
might come from the society, health workers, and family. Depression 
was defined as a mood disorder characterized by low mood, a feeling 
of sadness, and a general loss of interest in things. Family support 
was defined as the study subject’s perception of the positive support 
provided by the family for those activities pertinent to HIV treatment, 
which included financial, instrumental, emotional, and informational 
support. All of these key variables were measured by a pre-tested 
questionnaire. Depression was measured by pre-tested instrument 
called “Mini International Neuropsychiatric Interview” [15].
Data analysis
The current study employed path analysis for data analysis. Path 
analysis is the statistical technique that allows an examination of causal 
relationships between one or more independent variables, either 
continuous or categorical, and one or more dependent variables, either 
continuous or categorical. It is a second-generation multivariate method 
(the first generation being multiple regression) based on a linear equation 
system and was first developed by Sewall Wright in the 1930s [16]. The 
path analysis was run using Stata 13 [17].
Ethical clearance
Research ethics approval was granted by the Research Ethics Committee 
at Dr. Moewardi Hospital, Surakarta, Central Java, Indonesia. The 
research ethical approval was stated in the Letter of Ethical Approval 
Number 31/I/HREC/2018.
In data collection process, patients 18 or more years of age were asked 
to give informed consent, so that the study subjects were voluntarily 
participating in the research with full knowledge of relevant risks 
and benefits. The other key ethical principles that this study followed 
included: (1) Respect for participants, (2) Informed consent, (3) 
Voluntary participation and no coercion, (4) Right to withdraw, (5) 
No harm to participants, (6) Avoidance of undue intrusion, (7) No 
use of deception, (8) Preservation of anonymity, (9) Confidentiality of 
personal matters, and (10) Data protection.
RESULTS
Sample characteristics
Table 1 describes sample characteristics of this study. The majority of 
study subjects were male aged 35 years or over with senior high school 
level of education. Two-third of the sample were heterosexual and 
about a third were homosexual.
One of the encouraging findings from this study is that about four-fifth 
of the sampled HIV-infected patients received strong support from their 
families. “Only” about 10% of the sample got stigma or discrimination 
from either the society, health worker, or family. Another good finding is 
that about 90% of the sample had strong trust in health-care providers. 
As many as 13.4% of the sampled HIV-infected patients experienced 
high depression. The majority (78.5%) of the HIV-infected patients 
adhered to ART.
Path diagram
Fig. 1 depicts the final path diagram on the determinants of adherence 
to HIV/AIDS treatment, based on precede–proceed model. It shows 
that government supply of ART, patient knowledge, trust in provider, 
adverse effect, depression, stigma, and travel expenditure have direct 
effects on adherence to HIV treatment. Patient satisfaction, income, 
family support, discrimination, and distance to ART centers have 
indirect effects on HIV treatment.
Path analysis
Table 2 showed the effect estimates on the determinants of adherence 
to HIV treatment, based on precede–proceed model, using path analysis. 
As customary for reporting the path analysis output, the top-left panel 
of the table lists the independent variables that have direct effects on 
the dependent variable (i.e., adherence to HIV treatment). The bottom-
left panel of the table lists the independent variables that have direct 
effects on the dependent variable. The sign of the path coefficient 
indicates the direction of the effect, either increasing (+) or decreasing 
(–) with 0 indicating no effect (null hypothesis).
Because the dependent variable and all the independent variables 
were measured in dichotomous scale (dummy coded), basically the 
magnitude of path coefficient indicates the effect on the log odd of 
the dependent variable for a change (departure) from the reference 
category of an independent variable to the other category of the same 
independent variable, while taking account of the effects of all other 
variables in the path model.
All of the hypotheses on the relationships of variables in question 
were supported by data analysis. As hypothesized, government supply 
of ART (b=2.10; 95% confidence interval (CI)=0.85–3.36; p<0.001) 
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had a direct positive effect on adherence to HIV treatment, and it was 
statistically significant. Literally, government supply of ART increased 
the log odd of adherence to HIV treatment 2.10 units higher than a lack 
of government supply of ART. Likewise, patient knowledge (b=1.70; 
95% CI=0.43 to 2.95; p=0.008) and trust in provider (b=2.14; 95% 
CI=−0.58–4.87; p=0.123) had direct positive effects on adherence, and 
they were statistically significant. For example, high trust in provider 
increased the log odd of adherence to HIV treatment 2.14 units higher 
than low trust in provider.
As expected, adverse effect (b=−4.17; 95% CI=−6.87–−1.47; p=0.002) 
directly and negatively affected adherence to HIV treatment, and it was 
statistically significant. Likewise, depression (b=−2.38; 95% CI=−4.15–
−0.62 ; p=0.002), stigma (b=−4.10; 95% CI=−6.49–−1.71; p=0.008), 
and travel expenditure (b=−1.52; 95% CI=−2.68–−0.36; p<0.001), 
directly and negatively affected adherence, and they were statistically 
significant.
Patient satisfaction, income, and family support had indirect positive 
effects on adherence, whereas discrimination and distance to ART 
centers had indirect negative effects on adherence.
DISCUSSION
Adverse effect and adherence
The current study found that 12.3% of the sample HIV-infected 
patients experienced adverse effect (Table 1). Adverse effect was 
shown to negatively affect adherence to ART. This finding corroborates 
with previous studies. For example, a meta-analysis conducted by Al-
Dakkak et al. (2013), which combined 18 studies with ART-related 
adverse effect, reported that adherence to ART was significantly 
lower in patients with adverse effect than in patients who did not 
experience adverse effect (odds ratio=0.62; 95% CI=0.47–0.83). 
The specific AEs identified through this work as having significant 
negative implications for medication adherence included fatigue, 
cough, anxiety, confusion, taste disturbances, loss of appetite, and 
nausea [18].
As Al-Dakkak et al. (2013) added, in the context of combination ART 
regimens, confusion can be a major barrier to adherence since these 
regimens entail following detailed and complex recommendations 
pertaining to the timing, order, and combinations of multiple 
medications [18].
Depression and adherence
The present study found that depression negatively affected adherence 
to HIV treatment. This finding is consistent with a meta-analysis by 
Di Matteo et al. (2000), which reported that compared with non-
Table 1: Sample characteristics
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Fig. 1: Path diagram on the determinants of adherence to HIV/
AIDS treatment, based on precede–proceed model
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depressed patients, the odds of non-compliant with medical treatment 
recommendations among depressed patients were 3 times greater [19].
There are three possible underlying mechanisms by which depression 
might increase non-adherence. First, depression involves some degree 
of hopelessness and adherence might be difficult for a patient who 
lacks optimism that any action will be worthwhile. Second, depression 
is often accompanied by considerable social isolation and withdrawal 
from the individuals who would be essential in providing emotional 
support and assistance. Third, depression might be associated with 
reductions in the cognitive functioning essential to remembering 
and following through with treatment recommendations (e.g., taking 
medication) [19].
The result from the current study came from a cross-sectional data, 
so causal relationship whether depression causes non-adherence or 
non-adherence causes depression cannot be well established. Causal 
conclusions would require experimental assessment of a treatment 
intervention or causal modeling from longitudinal data. However, the 
authors have attempted an alternative path model with the direction of 
relationship running from adherence to depression, and the result was 
statistically non-significant estimate of effect, suggesting the direction 
of relationship running from depression to adherence seems to be more 
likely than the reverse direction.
Alternatively, it is possible that a “feedback loop” exists such that 
depression causes non-adherence to medical treatment and non-
adherence further exacerbates depression, with an implication that a 
clinical focus on both sides might be essential [19].
Stigma and adherence
Another factor which has been found in the current study to be associated 
with poor ART adherence is stigmatization. Stigma negatively affected 
adherence both directly and indirectly through discrimination and 
depression (Fig. 1). This finding is consistent with previous studies by 
Joglekar et al., Lyimo et al., and Prasitsuebsai et al. For example, Joglekar 
et al. (2011) reported that self-perceived stigma was reported to be the 
reasons for suboptimal adherence to ART in India [20-22].
As an explanation, stigmatization can cause depression, low self-
esteem, or psychiatric disorders [22-24], which in turn can lead to non-
adherence to treatment and poor health outcomes [22,25].
Trust in provider and adherence
The current study found that 90.8% of the sample had high trust in 
health-care providers (Table 1). Trust in health-care provider was 
shown to increase adherence. This finding gives clinical implication 
that trusting relationships between HIV-infected patients and health-
care providers are important to continuity of care. This finding 
supports the essential role that trust plays in effective doctor–patient 
relationships. Trust has been shown in previous studies to be a 
critical factor influencing a variety of important therapeutic processes 
including patient acceptance of therapeutic recommendations, 
adherence to recommendations, satisfaction with recommendations, 
satisfaction with medical care, symptom improvement, and patient 
disenrollment [26]. For example, a study by Abel and Efird (2013) 
reported that women with hypertension who trusted their health-
care providers were more likely to be adherent with their prescribed 
antihypertensive medications than those who did not trust their 
health-care providers [27].
Mutual trust, therefore, is essential to the patient–heath-care provider 
relationship and the achievement of positive health outcomes. 
To enhance trust, it is suggested that health-care providers show 
competence, caring behaviors, good interpersonal skills, and a desire to 
promote the health of the patients they serve [27].
Satisfaction, trust, depression, and adherence
The present study found that 76.8% of the sample experienced high 
satisfaction to the health services provided (Table 1). There are two 
different pathways by which satisfaction indirectly affects adherence. 
First, patient satisfaction increased trust in health-care provider, which 
finally increased adherence. Second, patient satisfaction lowered 
depression, which also finally increased adherence.
The indirect effects of satisfaction were slightly different from a study 
conducted in the US by Dang et al., which concluded that patient 
satisfaction had direct effects on retention in HIV care and adherence to 
HAART [28]. Dang et al. further highlighted the importance of business 
model of customer satisfaction and retention in the HIV care. They 
argued that patient satisfaction could serve as an innovative focus for 
increasing retention in HIV care and adherence to HAART, which in 
turn serves as key determinants of HIV suppression. Suppression of 
HIV replication represents the most important prognostic indicator for 
long-term survival with HIV infection [28].
Table 2: The results of path analysis on adherence to antiretroviral therapy among HIV/AIDS patients
Dependent variable Independent 
variable
Path coefficient 95% CI p
Lower Upper
Direct effect
Adherence Trust in provider 2.14 −0.58 4.87 0.123
Travel expenditure −1.52 −2.68 −0.36 <0.001
Government supply 2.10 0.85 3.36 <0.001 
Knowledge 1.70 0.43 2.95 0.008
Stigma −4.10 −6.49 −1.71 0.008
Depression −2.38 −4.15 −0.62 0.002
Adverse effect −4.17 −6.87 −1.47 0.879
Indirect effect
Travel expense Income −0.95 −1.50 −0.39 <0.001 
Distance 1.60 1.04 2.17 <0.001 
Depression Income −3.33 −5.38 −1.28 0.001 
Satisfaction −1.12 −2.09 −0.14 0.025 
Discrimination 4.57 2.46 6.68 <0.001
Family Support −1.62 −2.59 −0.64 0.001 
Trust Satisfaction 2.29 1.40 3.18 <0.001
Discrimination Stigma 5.43 4.06 6.80 <0.001 
Gender 1.27 −0.21 2.74 0.093 
n observation 284




Asian J Pharm Clin Res, Vol 11, Issue 11, 2018, 198-203
 Agustin, et al. 
Government supply of ART and adherence
The present study found that good government supply of ART improved 
its adherence. In Indonesia, the HIV regimens are provided free by 
the government at the designated public health facilities. During the 
initial phase of treatment, the HIV-infected patients received ART 
every 2 weeks. Given patients had no complaints during 2 weeks since 
the receipt of the first set of pills, the patients receive ART monthly. 
However, sometimes the patients received ART late leaving some 
untreated temporarily. About 172 (60.6%) of patients in this study 
received ART belatedly (Table 1).
Distance, travel expense, and adherence
The present study found that distance to ART centers and travel expense 
negatively affected adherence to ART; the farther distance, the larger 
travel expense, and the poorer adherence. This finding is consistent 
with a study by Shigdel et al. in Nepal, which reported that travel time 
to ART centers was independently and negatively associated with ART 
adherence. Likewise, in the study of Shigdel et al., higher cost of travel 
to ART center was independently and negatively associated with ART 
adherence [29].
Income, travel expense, and adherence
In the present study, income was shown to have a positive indirect effect 
on adherence through travel expense. Higher income was associated 
with less travel expense and less travel expense was associated with 
better adherence. The explanation for this might be that patients with 
higher income had more options to take the efficient mode to get to the 
ART center compared with patients with lower income, thereby faced 
with less travel expense. This finding is consistent with Shigdel et al. 
in Nepal, which also reported that higher income was associated with 
better ART adherence [29].
CONCLUSION
Government supply of ART, patient knowledge, and trust in health-care 
provider has direct positive effects on adherence to ART. Adverse effect, 
depression, stigma, and travel expenditure have direct negative effects 
on adherence to ART. Patient satisfaction, income, and family support 
have indirect positive effects on adherence to ART. Discrimination and 
distance to ART centers have indirect negative effects on adherence to 
ART. All of these determinants can be altered, improved, and capitalized, 
to develop a better system of care and support for an improved well-
being of HIV-infected patients.
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